ATYR (STOCKS)
aTyr Pharma, Inc. Common Stock
$0.810100
-0.022300 (-2.68%)
Prev close: $0.832400
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Sanjay S. Shukla
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $79.67M
- Employees
- 59
- P/E (TTM)
- -1.05
- P/B (TTM)
- 1.21
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
5
Buy
8
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.14 | $-0.19 | +0.0474 | +25.29% |
|
Sep 2025 (Q3)
|
$-0.26 | $-0.19 | -0.0727 | -38.81% |
|
Jun 2025 (Q2)
|
$-0.22 | $-0.19 | -0.0319 | -16.96% |
|
Mar 2025 (Q1)
|
$-0.17 | $-0.19 | +0.0238 | +12.28% |
Financial Statements
| Revenues | $190.00K |
| Benefits Costs and Expenses | $74.31M |
| Costs And Expenses | $74.31M |
| Nonoperating Income/Loss | $3.50M |
| Operating Expenses | $77.82M |
| Research and Development | $60.22M |
| Other Operating Expenses | $17.60M |
| Operating Income/Loss | -$77.63M |
| Income/Loss From Continuing Operations After Tax | -$74.12M |
| Income/Loss From Continuing Operations Before Tax | -$74.12M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$74.12M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$5.00K |
| Net Income/Loss Attributable To Parent | -$74.12M |
| Net Income/Loss Available To Common Stockholders, Basic | -$74.12M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.80 |
| Diluted Earnings Per Share | -$0.80 |
| Basic Average Shares | 92,985,359 |
| Diluted Average Shares | 92,985,359 |
| Assets | $93.00M |
| Current Assets | $80.24M |
| Prepaid Expenses | $677.00K |
| Other Current Assets | $79.56M |
| Noncurrent Assets | $12.77M |
| Fixed Assets | $4.26M |
| Other Non-current Assets | $8.50M |
| Liabilities | $25.72M |
| Current Liabilities | $15.15M |
| Accounts Payable | $3.89M |
| Wages | $2.99M |
| Other Current Liabilities | $8.27M |
| Noncurrent Liabilities | $10.57M |
| Equity | $67.29M |
| Equity Attributable To Noncontrolling Interest | -$192.00K |
| Equity Attributable To Parent | $67.48M |
| Liabilities And Equity | $93.00M |
| Net Cash Flow From Operating Activities | -$61.99M |
| Net Cash Flow From Operating Activities, Continuing | -$61.99M |
| Net Cash Flow From Investing Activities | -$5.05M |
| Net Cash Flow From Investing Activities, Continuing | -$5.05M |
| Net Cash Flow From Financing Activities | $66.01M |
| Net Cash Flow From Financing Activities, Continuing | $66.01M |
| Net Cash Flow | -$1.03M |
| Net Cash Flow, Continuing | -$1.03M |
| Comprehensive Income/Loss | -$74.09M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$5.00K |
| Comprehensive Income/Loss Attributable To Parent | -$74.09M |
| Other Comprehensive Income/Loss | $32.00K |